Click image to enlarge
The V-PLEX SARS-CoV-2 Panel 25 (IgM) Kit is a multiplex serology assay for antibodies to Spike antigens from variants of SARS-CoV-2. It includes antigens from Alpha, Beta, Delta and Omicron, including two BA.1 Spike antigens with extra mutations predicted to further evade neutralization. Panel 25 includes: A (WT), (B.1.1.7), (B.1.1.529; BA.1; B.1.15), (B.1.351), (B.1.617.2; AY.4) Alt Seq 2, (B.1.640.2), (BA.1+L452R), (BA.1+R346K; BA.1.1; BA.1.1.15), (BA.2; BA.2.1; BA.2.2; BA.2.3; BA.2.5; BA.2.6; BA.2.7; BA.2.8; BA.2.10; BA.2.10.1; BA.2.12), and (BA.3).
Note: Alternative S-GENE mutations for Spike of B.1.617.2 are listed as "Alt Seq #."
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Analyte(s)
|
|
SARS-CoV-2 Spike, SARS-CoV-2 Spike (B.1.1.7), SARS-CoV-2 Spike (B.1.1.529; BA.1), SARS-CoV-2 Spike (B.1.351), SARS-CoV-2 Spike (B.1.617.2; AY.4), SARS-CoV-2 Spike (B.1.640.2), SARS-CoV-2 Spike (BA.1+L452R), SARS-CoV-2 Spike (BA.1+R346K), SARS-CoV-2 Spike (BA.2), SARS-CoV-2 Spike (BA.3)
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Serum, Plasma, Saliva, Upper Respiratory Sample
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Serology Control 1.1
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Serology Control 1.2
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Serology Control 1.3
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Reference Standard 1
|
≤-70 °C
|
2 vial
(1 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(5 plate size)
|
|
|
|
SARS-CoV-2 Plate 25
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
2-8 °C
|
1 bottle
(1000 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Serology Control 1.1
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Serology Control 1.2
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Serology Control 1.3
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Reference Standard 1
|
≤-70 °C
|
10 vial
(1 mL)
|
|
|
|
|
2-8 °C
|
5 vial
(5 plate size)
|
|
|
|
SARS-CoV-2 Plate 25
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
|
2-8 °C
|
5 bottle
(1000 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
MSD Blocker A
|
RT
|
5 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Product Inserts
|
|
|
|
Handouts
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
|
|
|
|
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination
|
|
|
|
Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay
|
|
|
|
Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社